AzTrials
AzTrials

MyopiaPRICENCT02231606

Potentiating Rural Investment in Children's Eyecare (PRICE)

A study testing Free Glasses, Upgrade Glasses 1 and Upgrade Glasses 2 in people with Myopia, run by Sun Yat-sen University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the project is to create, study and advocate for a model that can be adopted by the Chinese government to provide spectacles for all children sustainable. Read more about this study

Who is it for?
Ages 7 to 12 years
Conditions the study is for
Myopia
What is being tested?
Free Glasses, Upgrade Glasses 1 and Upgrade Glasses 2
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10,234 participants
Where
1 siteChina
Study dates
Sep 2014to Jul 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Randomly selected primary schools, which has all 3, 4 and 5 grades, in the 9 project counties.
  • A class randomly selected from each grade of 3, 4, and 5 grades of the selected primary schools.
  • All children in the selected classes.

Who cannot join

  • Those schools that the total number of students are more than 2000.
  • Those schools that the total number of students of 3, 4, 5 grades are less than 80.
  • Children suffering from eye diseases such as cataract, congenital ptosis, strabismus, congenital glaucoma will not be included in the study and will be recommended referral.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Zhongshan Ophthalmic Center

    Guangzhou, Guangdong, 510060

Other trials in China

About this study

The aim of the project is to create, study and advocate for a model that can be adopted by the Chinese government to provide spectacles for all children sustainable.

Read the detailed description

Uncorrected refractive error (URE) is the leading cause of visual impairment among Chinese children, accounting for 90% or more of poor vision, and Chinese children have among the highest rates of myopia in the world. Despite the fact that the problem of URE is safely and inexpensively treated with glasses, only 15-40% of children needing them own and wear glasses sufficient to provide good vision in rural China.

PRICE (Potentiating Rural Investment in Children's Eyecare) will use a randomized, controlled design across 4 groups of all 138 schools in Yunnan (one of China's poorest provinces) and Guangdong (one of the richest) to optimize the model of "free glasses for all with an optional upgrade." The selection of free spectacles and cost of the "upgrade" options will be varied between groups in order to find the optimal balance between high rates of purchase of upgrade glasses on the one hand and good acceptance and wear of free spectacles among those selecting them on the other.

Conditions
Myopia
Being tested
Free Glasses, Upgrade Glasses 1, Upgrade Glasses 2
Keywords
Myopia Prevalence, Proportion of Purchase of free Spectacles, Proportion of Purchase of update Spectacles, Proportion of Wearing Spectacles
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Free GlassesOther

    Provide free glasses

  • Upgrade Glasses 1Other

    Provide optional purchase from range of spectacles, cheapest RMB100 (Mean price paid for glasses by Control families in Seeing is Learning I, subtracting one SD)

  • Upgrade Glasses 2Other

    Provide optional purchase from range of spectacles, cheapest RMB200 (Mean price paid for glasses by Control families in Seeing is Learning I, adding one SD)

Study groups in NCT02231606
Study groupRoleWhat they receive
Group 1: Pure ControlNo interventionProvision of glasses prescription only
Group 2: Free GlassesExperimentalFree glasses for all, no upgrade glasses offered
Receives: Other: Free Glasses
Group 3: Free + Upgrade Glasses 1ExperimentalFree glasses for all, optional purchase from range of spectacles, cheapest RMB100 (Mean price paid for glasses by Control families in Seeing is Learning I, subtracting one SD)
Receives: Other: Free Glasses; Other: Upgrade Glasses 1
Group 4: Free + Upgrade Glasses 2ExperimentalFree glasses for all, optional purchase from range of spectacles, cheapest RMB200 (Mean price paid for glasses by Control families in Seeing is Learning I, adding one SD)
Receives: Other: Free Glasses; Other: Upgrade Glasses 2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glasses purchase proportion

    Proportion of children in each group requiring glasses whose families select to purchase them.

    Measured: 8 months after the start of the project.

Secondary outcomes (1)
  1. Wearing spectacles proportion

    Proportion of children who actually wearing glasses at an unannounced check at endline survey.

    Measured: 8 months after the start of the project.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2014 (estimated)
  2. Study startSep 2014
  3. Primary completionJun 2015
  4. Study completionJul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
10,234 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02231606
Sponsor's protocol ID
ZOC-PRICE
Acronym
PRICE
Status last verified
Mar 2016
First submitted
31 Aug 2014
Last updated
9 Mar 2016
Results posted
No
Data monitoring committee
No

Publications

  • He M, Zeng J, Liu Y, Xu J, Pokharel GP, Ellwein LB. Refractive error and visual impairment in urban children in southern china. Invest Ophthalmol Vis Sci. 2004 Mar;45(3):793-9. doi: 10.1167/iovs.03-1051.

    PubMed 14985292
  • Zhou Z, Zeng J, Ma X, Pang X, Yi H, Chen Q, Meltzer ME, He M, Rozelle S, Congdon N. Accuracy of rural refractionists in western China. Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):154-61. doi: 10.1167/iovs.13-13250.

    PubMed 24327616
  • Li L, Lam J, Lu Y, Ye Y, Lam DS, Gao Y, Sharma A, Zhang M, Griffiths S, Congdon N. Attitudes of students, parents, and teachers toward glasses use in rural China. Arch Ophthalmol. 2010 Jun;128(6):759-65. doi: 10.1001/archophthalmol.2010.73.

    PubMed 20547954
  • He M, Zheng Y, Xiang F. Prevalence of myopia in urban and rural children in mainland China. Optom Vis Sci. 2009 Jan;86(1):40-4. doi: 10.1097/OPX.0b013e3181940719.

    PubMed 19104465
  • Wang X, Congdon N, Ma Y, Hu M, Zhou Y, Liao W, Jin L, Xiao B, Wu X, Ni M, Yi H, Huang Y, Varga B, Zhang H, Cun Y, Li X, Yang L, Liang C, Huang W, Rozelle S, Ma X. Cluster-randomized controlled trial of the effects of free glasses on purchase of children's glasses in China: The PRICE (Potentiating Rural Investment in Children's Eyecare) study. PLoS One. 2017 Nov 21;12(11):e0187808. doi: 10.1371/journal.pone.0187808. eCollection 2017.

    PubMed 29161286

Questions about this trial

What is this clinical trial studying?

A study testing Free Glasses, Upgrade Glasses 1 and Upgrade Glasses 2 in people with Myopia, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glasses purchase proportion (time frame: 8 months after the start of the project.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02231606, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in